Review: management of Parkinson&#39;s disease

Review: management of Parkinson&#39;s disease

David J Pedrosa, Lars Timmermann Department of Neurology, University Hospital Cologne, Cologne, Germany Abstract: Parkinson&#39;s disease (PD) is one of the most frequent neurological diseases. Despite the modern imaging and nuclear techniques which help to diagnose it in a very early stage...

Full description

Bibliographic Details
Main Authors:	Pedrosa DJ, Timmermann L
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-03-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/review-management-of-parkinson39s-disease-a12353

Similar Items

Sleep disturbances in Parkinson&#39;s disease patients and management options
by: Claassen DO, et al.
Published: (2011-12-01)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
by: Gaines KD, et al.
Published: (2012-07-01)

Genetic basis of Parkinson&#39;s disease: inheritance, penetrance, and expression
by: Schulte C, et al.
Published: (2011-06-01)

Investigational agents in the treatment of Parkinson&#39;s disease: focus on safinamide
by: Malek NM, et al.
Published: (2012-08-01)

The management of orthostatic hypotension in Parkinson's disease
by: Alvaro eSanchez-Ferro, et al.
Published: (2013-06-01)

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?
by: Sabrina Schr&ouml;der, et al.
Published: (2011-03-01)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
by: Hinz M, et al.
Published: (2016-06-01)

Nonmotor symptoms in Parkinson's disease: classification and management
by: Erro R, et al.
Published: (2015-01-01)

Potential sources of stem cells as a regenerative therapy for Parkinson&#39;s disease
by: Abir Oueida El-Sadik
Published: (2010-12-01)

Detection of retinal changes in Parkinson&#39;s disease with spectral-domain optical coherence tomography
by: Grant D Aaker, et al.
Published: (2010-12-01)

Pain management in patients with Parkinson's disease: challenges and solutions
by: Skogar O, et al.
Published: (2016-09-01)

Pisa syndrome in Parkinson's disease: diagnostic and management challenges
by: Miletić V
Published: (2016-04-01)

Clinical neurorestorative progress in Parkinson's disease
by: Chen L, et al.
Published: (2015-06-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

A role for the brain RAS in Alzheimer's and Parkinson's diseases
by: John William Wright, et al.
Published: (2013-10-01)

Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson&#39;s disease
by: Bradley J Robottom
Published: (2011-01-01)

Applications of yoga in Parkinson's disease: a systematic literature review
by: Rol, et al.
Published: (2014-01-01)

Animal models of Parkinson's disease and their applications
by: Park HJ, et al.
Published: (2016-07-01)

Parkinson's disease: carbidopa, nausea, and dyskinesia
by: Hinz M, et al.
Published: (2014-11-01)

Spotlight on olfactory dysfunction in Parkinson's disease
by: Rodríguez-Violante M, et al.
Published: (2017-06-01)

The 39-item Parkinson's Disease Questionnaire (PDQ-39): is it a unidimensional construct?
by: Peter Hagell, et al.
Published: (2009-07-01)

Validation of the Korean version of the 39-Item Parkinson's Disease Questionnaire (PDQ-39)
by: Hye-Ja Park, PhD, et al.
Published: (2014-03-01)

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
by: Ganguly G, et al.
Published: (2017-03-01)

Treatment of Parkinson&#39;s disease: nanostructured sol&ndash;gel silica&ndash;dopamine reservoirs for controlled drug release in the central nervous system
by: Tessy L&oacute;pez, et al.
Published: (2010-12-01)

Executive dysfunction in Parkinson's disease and timing deficits
by: Krystal L Parker, et al.
Published: (2013-10-01)

Amino acid management of Parkinson's disease: a case study [Corrigendum]
by: Hinz M, et al.
Published: (2016-06-01)

Managing fatigue in patients with Parkinson's disease: a patient-focused perspective
by: Ridder A, et al.
Published: (2016-07-01)

Cognition and dual-task performance in older adults with Parkinson's and Alzheimer's disease
by: Christofoletti G, et al.
Published: (2014-07-01)

Translation and validation of the Persian version of the 39 item Parkinson’s Disease Questionnaire (PDQ-39)
by: Marzieh Nojomi, et al.
Published: (2010-01-01)

Erratum: The promise of neuroprotective agents in Parkinson's disease
by: Stacey E Seidl, et al.
Published: (2013-05-01)

Morning akinesia in Parkinson's disease: challenges and solutions
by: Tambasco N, et al.
Published: (2016-06-01)

Protective microglia and its regulation in Parkinson's disease
by: Weidong Le, et al.
Published: (2016-09-01)

Bupropion interferes with the image diagnosis of Parkinson's disease
by: Lin CH, et al.
Published: (2017-10-01)

Reliability and Validity of 39-Item Parkinson’s Disease Questionnaire and Parkinson’s Disease Quality of Life Questionnaire
by: Joana Jesus-Ribeiro, et al.
Published: (2017-05-01)

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
by: Daniel D Truong
Published: (2009-03-01)

Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa
by: Isaacson SH, et al.
Published: (2014-04-01)

Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
by: Sandy eStayte, et al.
Published: (2014-05-01)

Communication impairment in patients with Parkinson's disease: challenges and solutions
by: Holtgraves T, et al.
Published: (2016-05-01)

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease
by: Lucy Mary Collins, et al.
Published: (2016-05-01)

Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
by: Lai Taavi, et al.
Published: (2008-03-01)